Stefania Baraldi

1.1k total citations
29 papers, 906 citations indexed

About

Stefania Baraldi is a scholar working on Organic Chemistry, Physiology and Molecular Biology. According to data from OpenAlex, Stefania Baraldi has authored 29 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 13 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Stefania Baraldi's work include Adenosine and Purinergic Signaling (13 papers), Synthesis and Biological Evaluation (12 papers) and Synthesis and biological activity (9 papers). Stefania Baraldi is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Synthesis and Biological Evaluation (12 papers) and Synthesis and biological activity (9 papers). Stefania Baraldi collaborates with scholars based in Italy, United States and Spain. Stefania Baraldi's co-authors include Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Pier Andrea Borea, Romeo Romagnoli, Stefania Gessi, Katia Varani, Stefania Merighi, Giulia Saponaro, Delia Preti and Allan R. Moorman and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Cellular Physiology.

In The Last Decade

Stefania Baraldi

29 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Baraldi Italy 18 398 370 236 116 103 29 906
Tadeusz Karcz Poland 20 492 1.2× 339 0.9× 169 0.7× 157 1.4× 174 1.7× 63 959
Pedro Besada Spain 20 439 1.1× 388 1.0× 404 1.7× 95 0.8× 76 0.7× 50 964
Teresa Domènech Spain 17 434 1.1× 282 0.8× 55 0.2× 125 1.1× 178 1.7× 29 915
Artem Kondratskyi France 13 416 1.0× 62 0.2× 81 0.3× 30 0.3× 162 1.6× 18 806
Hayato Fukuda Japan 18 213 0.5× 322 0.9× 40 0.2× 66 0.6× 63 0.6× 61 848
Aliaa Abdelrahman Germany 21 442 1.1× 246 0.7× 657 2.8× 47 0.4× 108 1.0× 38 1.0k
Yanhong Xing China 14 252 0.6× 149 0.4× 46 0.2× 30 0.3× 92 0.9× 28 580
Jutta Hegler Germany 9 742 1.9× 153 0.4× 371 1.6× 40 0.3× 211 2.0× 10 1.1k
Erol K. Bayburt United States 15 348 0.9× 261 0.7× 22 0.1× 56 0.5× 117 1.1× 17 964
Nicola Sassi Italy 14 615 1.5× 80 0.2× 33 0.1× 23 0.2× 122 1.2× 18 844

Countries citing papers authored by Stefania Baraldi

Since Specialization
Citations

This map shows the geographic impact of Stefania Baraldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Baraldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Baraldi more than expected).

Fields of papers citing papers by Stefania Baraldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Baraldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Baraldi. The network helps show where Stefania Baraldi may publish in the future.

Co-authorship network of co-authors of Stefania Baraldi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Baraldi. A scholar is included among the top collaborators of Stefania Baraldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Baraldi. Stefania Baraldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romagnoli, Romeo, Filippo Prencipe, Paola Oliva, et al.. (2019). Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors. Journal of Medicinal Chemistry. 62(3). 1274–1290. 39 indexed citations
2.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Stefania Baraldi, et al.. (2018). Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors. Journal of Medicinal Chemistry. 61(3). 1340–1354. 40 indexed citations
3.
Romagnoli, Romeo, Pier Giovanni Baraldi, Filippo Prencipe, et al.. (2017). Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents. European Journal of Medicinal Chemistry. 134. 258–270. 28 indexed citations
4.
Romagnoli, Romeo, Pier Giovanni Baraldi, Filippo Prencipe, et al.. (2017). Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents. Scientific Reports. 7(1). 46356–46356. 19 indexed citations
5.
Romagnoli, Romeo, María Kimatrai Salvador, Pier Giovanni Baraldi, et al.. (2017). 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. European Journal of Medicinal Chemistry. 143. 683–698. 20 indexed citations
6.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.. (2016). Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists. European Journal of Medicinal Chemistry. 113. 11–27. 38 indexed citations
7.
Romagnoli, Romeo, Pier Giovanni Baraldi, Filippo Prencipe, et al.. (2016). Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole. Scientific Reports. 6(1). 26602–26602. 32 indexed citations
8.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.. (2015). Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH). European Journal of Medicinal Chemistry. 97. 289–305. 18 indexed citations
9.
Baraldi, Pier Giovanni, Stefania Baraldi, Giulia Saponaro, et al.. (2015). One-Pot Reaction To Obtain N,N′-Disubstituted Guanidines of Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold as Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 58(13). 5355–5360. 7 indexed citations
10.
Romagnoli, Romeo, Pier Giovanni Baraldi, María Dora Carriòn, et al.. (2013). Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A1 adenosine receptor. Bioorganic & Medicinal Chemistry. 22(1). 148–166. 11 indexed citations
11.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Giulia Saponaro, et al.. (2013). Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists. Journal of Medicinal Chemistry. 56(3). 1098–1112. 17 indexed citations
12.
Baraldi, Pier Giovanni, Giulia Saponaro, Romeo Romagnoli, et al.. (2012). Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 55(11). 5380–5390. 5 indexed citations
13.
Baraldi, Pier Giovanni, Romeo Romagnoli, Giulia Saponaro, et al.. (2012). 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation. Bioorganic & Medicinal Chemistry. 20(5). 1690–1698. 25 indexed citations
14.
Baraldi, Pier Giovanni, Stefania Baraldi, Giulia Saponaro, et al.. (2011). Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2BAdenosine Receptor Antagonists. Journal of Medicinal Chemistry. 55(2). 797–811. 15 indexed citations
15.
Baraldi, Pier Giovanni, Delia Preti, Abdel Naser Zaid, et al.. (2011). New 2-Heterocyclyl-imidazo[2,1-i]purin-5-one Derivatives as Potent and Selective Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 54(14). 5205–5220. 11 indexed citations
16.
Baraldi, Pier Giovanni, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.. (2011). Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 20(2). 1046–1059. 23 indexed citations
17.
Baraldi, Pier Giovanni, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.. (2008). Structure–activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A3 adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 16(24). 10281–10294. 10 indexed citations
18.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Delia Preti, et al.. (2007). 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 16(5). 2419–2430. 10 indexed citations
19.
Gessi, Stefania, Stefania Merighi, Katia Varani, et al.. (2007). Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: Focus on the A3adenosine subtype. Journal of Cellular Physiology. 211(3). 826–836. 95 indexed citations
20.
Baraldi, Pier Giovanni, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.. (2007). N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor. Bioorganic & Medicinal Chemistry. 15(7). 2514–2527. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadeusz Karcz Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Teresa Domènech Breakdown of academic impact, for papers by Artem Kondratskyi Breakdown of academic impact, for papers by Hayato Fukuda Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Yanhong Xing Breakdown of academic impact, for papers by Jutta Hegler Breakdown of academic impact, for papers by Erol K. Bayburt Breakdown of academic impact, for papers by Nicola Sassi
Rankless by CCL
2026